Tachycardia-induced Cardiomyopathy (Tachycardiomyopathy)

Area of Science:

• Cardiology
• Electrophysiology
• Heart Failure

Background:

• Tachycardia-induced cardiomyopathy (TIC) is left ventricular dysfunction caused by chronic rapid heart rates (tachyarrhythmia).
• TIC is observed in experimental models and human patients with incessant tachyarrhythmias.
• It is known to be reversible upon controlling the heart rate.

Purpose of the Study:

• To review the understanding of tachycardia-induced cardiomyopathy.
• To highlight the reversibility of left ventricular dysfunction after heart rate control.
• To increase clinical awareness of TIC in patients with unexplained systolic dysfunction.

Main Methods:

• Review of experimental data and clinical case reports on tachycardia-induced cardiomyopathy.
• Analysis of outcomes following various heart rate control strategies.
• Emphasis on diagnostic criteria based on functional improvement after rhythm normalization.

Main Results:

• Rate control through cardioversion, medications, or ablation significantly improves systolic function.
• Marked improvement in left ventricular function post-heart rate normalization is a key diagnostic indicator.
• TIC is a significant cause of reversible systolic dysfunction.

Conclusions:

• Tachycardia-induced cardiomyopathy is a distinct clinical entity characterized by reversible left ventricular dysfunction.
• Effective management of tachyarrhythmias is critical for improving cardiac function in affected patients.
• Clinicians should consider TIC in the differential diagnosis of unexplained systolic dysfunction.